Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
M Hernandez-Santillan1, M Martínez-Castillo1, Z Medina-Ávila1, M Lemus-Peña1, D Montes de Oca-Ángeles1, A Hernández-Barragan1, JL Pérez-Hernández2, F Higuera-De la Tijera2, D Santana-Vargas2, P Cordero-Pérez3, L Muñoz-Espinoza3, J Córdova-Gallardo4, D Kershenobich1,5, G Gutiérrez-Reyes1
1 Liver, Pancreas and Motility laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. Mexico
2 Department of Gastroenterology. General Hospital of México “Dr. Eduardo Liceaga.” México City. México
3 Universitary Hospital “Dr. José Eluterio González”. School of Medicine. UANL. Nuevo Leon. México City. México
4 General Hospital “Dr. Manuel Gea González”. México City. México
5 National Institute of Medical Sciences and Nutrition “Salvador Zubirán.” México City. México
Read
536
Timeswas read the article
169
Total PDF
367
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 2 | 11 |
| 2025 11 | 32 | 23 | 55 |
| 2025 10 | 21 | 7 | 28 |
| 2025 9 | 22 | 14 | 36 |
| 2025 8 | 22 | 18 | 40 |
| 2025 7 | 29 | 8 | 37 |
| 2025 6 | 16 | 1 | 17 |
| 2025 5 | 17 | 2 | 19 |
| 2025 4 | 7 | 2 | 9 |
| 2025 3 | 19 | 3 | 22 |
| 2025 2 | 16 | 3 | 19 |
| 2025 1 | 11 | 1 | 12 |
| 2024 12 | 9 | 3 | 12 |
| 2024 11 | 13 | 4 | 17 |
| 2024 10 | 8 | 0 | 8 |
| 2024 9 | 8 | 2 | 10 |
| 2024 8 | 11 | 4 | 15 |
| 2024 7 | 13 | 3 | 16 |
| 2024 6 | 9 | 2 | 11 |
| 2024 5 | 12 | 1 | 13 |
| 2024 4 | 11 | 3 | 14 |
| 2024 3 | 3 | 6 | 9 |
| 2024 2 | 3 | 3 | 6 |
| 2024 1 | 3 | 11 | 14 |
| 2023 12 | 2 | 3 | 5 |
| 2023 11 | 8 | 6 | 14 |
| 2023 10 | 5 | 7 | 12 |
| 2023 9 | 0 | 2 | 2 |
| 2023 8 | 9 | 3 | 12 |
| 2023 7 | 5 | 3 | 8 |
| 2023 6 | 9 | 11 | 20 |
| 2023 5 | 0 | 3 | 3 |
| 2023 4 | 2 | 3 | 5 |
| 2023 3 | 0 | 1 | 1 |
| 2023 2 | 3 | 1 | 4 |
Show all
